Research suggests that Infliximab can suppress H. pylori–induced upregulation of CXCR4 by inhibiting TNF-α signaling, thereby reducing GC cell migration and exhibiting anti-tumor potential (434). The gene discussed is TNF; the disease is neoplasm.